How does inflammation drive mutagenesis in colorectal cancer?

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Colorectal cancer (CRC) is a significant global health concern with complex etiology.
• Known CRC risk factors include diet, obesity, inflammation, and genetic predisposition.
• Current understanding of CRC's mechanistic drivers is insufficient to explain complex interactions.

Purpose of the Study:

• To address the conundrum of C to T mutations in CRC, which are not typically caused by oxidative damage.
• To elucidate the potential role of nucleotide excision repair (NER) and base excision repair (BER) pathways in linking oxidative DNA damage to C to T mutations.
• To explore how emerging technologies can advance the understanding of CRC initiation and prevention.

Main Methods:

• Review of existing literature on CRC etiology, DNA mutations, and repair pathways.
• Analysis of the discrepancy between expected oxidative DNA damage mutations (G to T) and observed CRC mutations (C to T).
• Discussion of the potential roles of NER and BER in mediating specific mutation types.

Main Results:

• Observed recurrent mutations in CRC are predominantly C to T transitions at CpG sites, linked to 5-methylcytosine deamination.
• Oxidative DNA damage typically induces G to T transversions, creating a conflict with observed CRC mutation patterns.
• NER and BER pathways are implicated as potential mediators connecting oxidative damage to C to T mutations.

Conclusions:

• The interplay between NER and BER pathways may explain the prevalence of C to T mutations in CRC despite oxidative stress.
• Next-generation sequencing technologies offer novel approaches to study DNA damage, repair, and mutagenesis in human tissues.
• These technologies could lead to mechanism-based biomarkers for early CRC diagnosis and improved prevention strategies.